Loading...

PE anti-mouse CD150 (SLAM) Antibody

Pricing & Availability
Clone
TC15-12F12.2 (See other available formats)
Regulatory Status
RUO
Other Names
Signaling Lymphocyte Activation Molecule (SLAM), IPO-3
Isotype
Rat IgG2a, λ
Ave. Rating
Submit a Review
Product Citations
publications
TC15-12F12.2
C57BL/6 mouse splenocytes were stained with CD150 (clone TC15-12F12.2) PE (solid line) or rat IgG2a PE isotype control (broken line).
  • TC15-12F12.2
    C57BL/6 mouse splenocytes were stained with CD150 (clone TC15-12F12.2) PE (solid line) or rat IgG2a PE isotype control (broken line).
  • TC15-12F12_PE_2_102110
    C57BL/6 mouse bone marrow cells were stained with CD150 (clone TC15-12F12.2) PE (filled histogram) or rat IgG2a PE isotype control (open histogram) (gated on lymphoid cell population).
Compare all formats See PE spectral data
Cat # Size Price Quantity Check Availability Save
115903 25 µg $104
Check Availability


Need larger quantities of this item?
Request Bulk Quote
115904 100 µg $268
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD150 is a 75-95 kD member of the immunoglobulin superfamily, also known as SLAM (signaling lymphocyte activation molecule) or IPO-3. CD150, a single chain type I transmembrane molecule, is expressed on thymocytes, T cell subsets, B cells, dendritic cells, and endothelial cells. The expression is upregulated upon activation. CD150 expression has been shown to be maintained on Th1 but not Th2 clones. T regulatory cells express a relatively high level of CD150. Antibodies against CD150 have been shown to augment IFN-γ production by Th1 cells, especially when co-stimulated through the TCR. CD150 associates with the src homology 2-domain-containing protein tyrosine phosphatase SHP-2, and this association is thought to be involved in signal transduction. In combination with CD48, CD150 is a useful marker for hematopoietic stem cell studies.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse SLAM-human IgG1 fusion protein
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD150 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The TC15-12F12.2 antibody has been reported to enhance the production of IFN-? by Th1 cells stimulated through TCR. Additional reported applications (for the relevant formats) include: immunoprecipitaion17, enhancing IFN-? production by Th1 cells when stimulated with CD31, and inhibiting CD3 induced T cell proliferation6. The Ultra-LEAF™ purified antibody (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 115949 & 115950).

Application References

(PubMed link indicates BioLegend citation)
  1. Castro AG, et al. 1999. J. Immunol. 163:5860. (FC, Costim, IP)
  2. Forsberg EC, et al. 2005. PLoS Genet. 1:e28. (FC)
  3. Terrazas LI, et al. 2005. Int. J. Parasitol. 35:1349. (FC)
  4. Cannons JL, et al. 2006. J. Exp. Med. 203:1551. (FC)
  5. Umemoto T, et al. 2006. J. Immunol. 177:7733. (FC)
  6. Jordan MA, et al. 2007. J. Immunol. 178:1618. (FC, Block) PubMed
  7. Jung Y, et al. 2007. Blood 110:82. PubMed
  8. Pimanda JE, et al. 2007. Proc. Natl. Acad. Sci. USA 104:840.
  9. Sugiyama T, et al. 2007. Proc. Natl. Acad. Sci. USA 104:175.
  10. Kim I, et al. 2006. Blood 108:737. PubMed
  11. Ema H, et al. 2006. Nat Protoc. 1:2979. PubMed
  12. Fraser ST, et al. 2007. Blood 109:4616. PubMed
  13. Jung Y, et al. 2008. Stem Cells. 26:2042. Pubmed
  14. Song J, et al. 2010. Blood 115:2592. PubMed
  15. Cridland SO, et al. 2009. Blood Cell. Mol. Dis. 43:149. (FC) PubMed
  16. Morita Y, et al. 2010. J. Exp Med. 207:1173. PubMed
  17. Talaei N, et al. 2015. J. Immunol. 195(10):4623. PubMed
Product Citations
  1. Soukup AA, et al. 2019. J Clin Invest. 129:1180. PubMed
  2. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  3. Ho TT, et al. 2021. J Exp Med. 218:. PubMed
  4. Jabbar S, et al. 2022. Exp Hematol Oncol. 11:83. PubMed
  5. Hu W, et al. 2015. Blood. 125:2206. PubMed
  6. Pietras E, et al. 2016. Nat Cell Biol. 10.1038/ncb3346. PubMed
  7. Chen Q, et al. 2019. Cell Stem Cell. 25(6):768-783.e6. PubMed
  8. Hirata Y et al. 2018. Cell stem cell. 22(3):445-453 . PubMed
  9. Nita A, et al. 2021. Cell Reports. 34(5):108688. PubMed
  10. Maltby S, et al. 2014. J Immunol. 193:4072. PubMed
  11. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  12. Thomas GE, et al. 2022. Nat Cell Biol. 24:872. PubMed
  13. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  14. Wei Q, et al. 2021. Nat Commun. 12:2522. PubMed
  15. Gao B, et al. 2018. Aging Cell. 3. PubMed
  16. Zhao M, et al. 2019. Cell Rep. 26:652. PubMed
  17. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  18. Kobayashi H, et al. 2020. STAR Protoc. 1:100078. PubMed
  19. Jung Y, et al. 2008. Stem Cells. 26:2042. PubMed
  20. Fujino T, et al. 2021. Nat Commun. 12:1826. PubMed
  21. Li CC, et al. 2022. Nat Commun. 13:346. PubMed
  22. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  23. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  24. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  25. Nakamura‐Ishizu A et al. 2018. Cell reports. 25(7):1772-1785 . PubMed
  26. Kokkaliaris K, et al. 2016. Blood. 128: 1181 - 1192. PubMed
  27. Greenbaum A, et al. 2012. Blood. 120:295. PubMed
  28. Ganuza M, et al. 2017. Exp Hematol. 10.1016/j.exphem.2017.04.006. PubMed
  29. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
  30. Baccelli I, et al. 2020. Cancer Cell. 36(1):84-99. PubMed
  31. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  32. Kim SP, et al. 2021. Cell Reports. 36(9):109626. PubMed
  33. Jordan M, et al. 2007. J Immunol. 178:1618. PubMed
  34. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  35. Mooney C, et al. 2017. International Journal of Molecular Sciences. 10.3390/ijms18051037. PubMed
  36. Kinkel SA, et al. 2022. iScience. 25:104684. PubMed
  37. Jia W, et al. 2021. Nat Commun. 12:2118. PubMed
  38. Leiva M, et al. 2016. Nat Commun. 7:10222. PubMed
  39. Grassinger J, et al. 2012. Cytokine. 58:218. PubMed
  40. Jung Y, et al. 2011. Exp Hematol. 39:151. PubMed
  41. Breitbach M, et al. 2018. Cell Stem Cell. 1.098611111. PubMed
  42. Tadokoro Y, et al. 2018. Cell Stem Cell. 1.411805556. PubMed
  43. Ise W, et al. 2018. Immunity. 48:702. PubMed
  44. Comazzetto S et al. 2018. Cell stem cell. 24(3):477-486 . PubMed
  45. Kim I, et al. 2006. Blood. 108:737. PubMed
  46. Dong S, et al. 2021. Nature. 591:117. PubMed
  47. Zhang J, et al. 2015. Leukemia. 29 1847 . PubMed
  48. Bahal R, et al. 2016. Nat Commun. 7:13304. PubMed
  49. Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed
  50. Morita Y, et al. 2010. J Exp Med. 207:1173. PubMed
  51. Jung Y, et al. 2007. Blood . 110:82. PubMed
  52. Nagai M, et al. 2020. Cell. 178(5):1072-1087.e14.. PubMed
  53. Hsu JI et al. 2018. Cell stem cell. 23(5):700-713 . PubMed
  54. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  55. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  56. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  57. Witkowski MT, et al. 2020. Cancer Cell. 37:867. PubMed
  58. Montecino-Rodriguez E, et al. 2020. STAR Protoc. 1:100159. PubMed
  59. Chiba H, et al. 2013. Am J Physiol Cell Physiol. 305:693. PubMed
  60. Seneviratne AK, et al. 2019. Cell Stem Cell. 24:621. PubMed
  61. Nacson J, et al. 2020. Molecular Cell. 78(5):951-959. PubMed
  62. Du J, et al. 2012. Stem Cells. 30:1447. PubMed
  63. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  64. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  65. Song J, et al. 2010. Blood. 115:2592. PubMed
  66. van Oostrum M, et al. 2019. Nat Commun. 4.398611111. PubMed
  67. Williams JW, et al. 2017. Circ Res. 121:662. PubMed
  68. Pierce H, et al. 2017. Cell Stem Cell. 1.283333333. PubMed
  69. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  70. Pinho S et al. 2018. Developmental cell. 44(5):634-641 . PubMed
  71. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  72. Yang S, et al. 2022. J Exp Med. 219:. PubMed
  73. Sacma M, et al. 2022. STAR Protoc. 3:101483. PubMed
  74. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  75. Philip E Boulais et al. 2018. Immunity. 49(4):627-639 . PubMed
  76. Balzano M et al. 2019. Cell reports. 26(12):3257-3271 . PubMed
  77. Kobayashi H, et al. 2020. Cell Reports. 28(1):145-158.e9.. PubMed
  78. Garaycoechea JI, et al. 2018. Nature. 553:171. PubMed
  79. Thongthip S, et al. 2016. Genes Dev. 30: 645 - 659. PubMed
  80. Wang X, et al. 2018. Stem Cell Reports. 11:274. PubMed
  81. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  82. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  83. Wei Q, et al. 2020. Dev Cell. 53:503. PubMed
  84. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  85. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  86. Kaplan I, et al. 2011. J Immunol. 186:2826. PubMed
  87. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  88. Fischer KC, et al. 2021. Cell Death Dis. 12:28. PubMed
  89. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  90. Zhang J, et al. 2015. J Biol Chem. 290 19093 . PubMed
  91. Ley C, et al. 2015. Cancer Cell. 27: 631-43. PubMed
  92. Keerthivasan S, et al. 2021. Immunity. 54(7):1511-1526.e8. PubMed
  93. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  94. Xu C, et al. 2018. Nat Commun. 9:2449. PubMed
  95. Soukup AA, et al. 2021. Sci Adv. 7:eabk3521. PubMed
  96. Gao X, et al. 2021. Nature. 589:591. PubMed
  97. Alvarez S, et al. 2015. Nat Commun. 6: 8548. PubMed
  98. Theocharides A, et al. 2012. J Exp Med. 209:1883. PubMed
  99. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  100. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  101. DeVilbiss AW, et al. 2021. eLife. 10:00. PubMed
  102. Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
  103. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  104. Li K, et al. 2020. Nat Commun. 0.795138889. PubMed
  105. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  106. Yamashita M, et al. 2019. Cell Stem Cell. 25:357. PubMed
  107. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  108. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  109. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  110. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  111. Zhou J, et al. 2019. Cell Stem Cell. 24:285. PubMed
  112. Fraser S, et al. 2007. Blood. 109:343. PubMed
  113. Yang L, et al. 2021. Front Immunol. 12:722273. PubMed
  114. Asada N, et al. 2017. Nat Cell Biol. 19:214-223. PubMed
  115. Kang YA, et al. 2020. J Exp Med. 217:00:00. PubMed
  116. Xie M, et al. 2020. Haematologica. . PubMed
  117. Tan DQ, et al. 2019. Cell Rep. 26:2316. PubMed
  118. Man N, et al. 2021. JCI Insight. 6:. PubMed
  119. Gu Z, et al. 2021. Nat Genet. 53:672. PubMed
  120. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
RRID
AB_313682 (BioLegend Cat. No. 115903)
AB_313683 (BioLegend Cat. No. 115904)

Antigen Details

Structure
Ig superfamily, 75-95 kD
Distribution

Thymocytes, T cell subset, B lymphocytes, dendritic cells, endothelial cells

Function
B cell and dendritic cell costimulation
Ligand/Receptor
CD150
Cell Type
B cells, Dendritic cells, Endothelial cells, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology, Innate Immunity
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Cocks BG, et al. 1995. Nature 376:260.
2. Punnonen J, et al. 1997. J. Exp. Med. 185:993.
3. Sidorenko SP, et al. 1993. J. Immunol. 151:4614.

Gene ID
27218 View all products for this Gene ID
UniProt
View information about CD150 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account